84.48
Billiontoone Inc Borsa (BLLN) Ultime notizie
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), BillionToOne, Inc. Class A (BLLN) and Solventum Corporation (SOLV) - The Globe and Mail
Does BillionToOne (BLLN) Have the Potential to Rally 37% as Wall Street Analysts Expect? - Zacks Investment Research
Top Billiontoone (BLLN) Competitors 2026 - MarketBeat
Transcript : BillionToOne, Inc., Q1 2026 Earnings Call, May 06, 2026 - marketscreener.com
BLLN Technical Analysis | Trend, Signals & Chart Patterns | BILLIONTOONE INC CL A (NASDAQ:BLLN) - ChartMill
BillionToOneStarting 2026 Strong (NASDAQ:BLLN) - Seeking Alpha
BLLN Stock Price, Quote & Chart | BILLIONTOONE INC CL A (NASDAQ:BLLN) - ChartMill
Jim Cramer on BillionToOne: “I Say Buy It” - Insider Monkey
BillionToOne Launches Non-Invasive Prenatal Confirmation Test Using Fetal Cells - Clinical Lab Products
BillionToOne's (NASDAQ:BLLN) Strong Earnings Are Of Good Quality - 富途牛牛
Cramer: Design Therapeutics Is ‘Pure Spec,’ Buy This Health Care StockBillionToOne (NASDAQ:BLLN), Desi - Benzinga
Cramer's lightning round: Buy BillionToOne - MSN
BillionToOne (NASDAQ:BLLN) Momentum Fuels Nasdaq Healthcare Interest - Kalkine Media
BillionToOne (BLLN) NeoTribe funds shift 465,607 shares in internal move - Stock Titan
Fund and trust transfers reshape BillionToOne (BLLN) share stake - Stock Titan
Guggenheim Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $120 - Moomoo
Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year? - Yahoo Finance
BillionToOne's (NASDAQ:BLLN) Earnings May Just Be The Starting Point - simplywall.st
Solid Earnings Reflect BillionToOne's (NASDAQ:BLLN) Strength As A Business - Yahoo Finance
Guggenheim raises BillionToOne stock price target to $120 on reimbursement progress - Investing.com Nigeria
Guggenheim raises BillionToOne stock price target to $120 on reimbursement progress By Investing.com - Investing.com South Africa
BillionToOne Q1 2026 slides: 84% revenue surge, GAAP profitability By Investing.com - Investing.com South Africa
Why BillionToOne Stock Is Suddenly Sliding - TipRanks
BillionToOne Q1 2026 slides: 84% revenue surge, GAAP profitability - Investing.com
Earnings call transcript: BillionToOne Q1 2026 earnings surge, stock jumps - Investing.com
Earnings call transcript: BillionToOne Q1 2026 earnings surge, stock jumps By Investing.com - Investing.com Nigeria
BillionToOne Stock 5-Day Winning Spree: Stock Climbs 47% - Trefis
5-Day Rally Sends BillionToOne Stock Up 47% - Trefis
Why BillionToOne Shares Are Suddenly Soaring - TipRanks
TradingKey - TradingKey
BillionToOne (BLLN) reports Q1 earnings: What key metrics have to say - MSN
Wall Street analysts predict a 25.63% upside in BillionToOne (BLLN): Here's what you should know - MSN
Discover May 2026's Top Stocks Estimated Below Intrinsic Value - Sahm
AI Model Lifts Score on BillionToOne (BLLN) After Earnings Turnaround - TipRanks
Number of shareholders of BillionToOne, Inc. – NASDAQ:BLLN - TradingView
BillionToOne, Inc. (BLLN) Eps Diluted (TTM) - Zacks Investment Research
Wall Street Analysts Predict a 25.63% Upside in BillionToOne (BLLN): Here's What You Should Know - Yahoo Finance
BTIG Sticks to Their Buy Rating for BillionToOne, Inc. Class A (BLLN) - The Globe and Mail
Analysts Have Conflicting Sentiments on These Healthcare Companies: BillionToOne, Inc. Class A (BLLN) and Bio-Techne (TECH) - The Globe and Mail
Billiontoone (NASDAQ:BLLN) Price Target Raised to $125.00 at JPMorgan Chase & Co. - MarketBeat
Illumina Patent Lawsuit Targets BillionToOne Prenatal Tests (1) - Bloomberg Law News
Billiontoone (NASDAQ:BLLN) Shares Up 10.6% Following Better-Than-Expected Earnings - MarketBeat
BillionToOne, Inc. Reports Strong Q1 2026 Revenue Growth and Profitability in Latest 10-Q Filing - Minichart
Piper Sandler Maintains BillionToOne(BLLN.US) With Buy Rating, Cuts Target Price to $130 - Moomoo
A Quick Look at Today's Ratings for BillionToOne(BLLN.US), With a Forecast Between $100 to $145 - Moomoo
BTIG Research Issues Pessimistic Forecast for Billiontoone (NASDAQ:BLLN) Stock Price - MarketBeat
BillionToOne, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
BillionToOne Q1 2026 slides: 84% revenue surge, 73% gross margin By Investing.com - Investing.com Australia
Earnings call transcript: BillionToOne’s Q1 2026 revenue surges 84% YoY By Investing.com - Investing.com South Africa
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):